Dominik Maurer - Concepedia

Author

Dominik Maurer

Immatics Biotechnologies (Germany)ORCID

Also Known As

D Maurer, D. Maurer, DOMINIK MAURER, Dominik Maurer

185

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Immatics Biotechnologies (Germany)University of Tübingen University of Southampton The University of Texas MD Anderson Cancer Center Johannes Gutenberg University Mainz

About

Dominik Maurer is an author at Immatics Biotechnologies (Germany) specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	2.2K
2	Engineering	1	1	36
3	Health Sciences	1	1	10
4	Natural Sciences	1	1	36
5	Applied Physics	1	1	36

Dominik Maurer

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Actively personalized vaccination trial for newly diagnosed glioblastoma Norbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, Nature VaccinationNeuro-oncologyVaccination TrialVaccine TrialTherapeutic Vaccine	2018	897
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival Steffen Walter, Toni Weinschenk, Arnulf Stenzl, Nature Medicine VaccinationCancer ImmunosurveillanceMultipeptide Immune ResponseMedicineCancer Vaccine Ima901	2012	777
IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial Brian I. Rini, Arnulf Stenzl, Romauld Zdrojowy, The Lancet Oncology Sunitinib Versus SunitinibUrologyGenitourinary CancerMedicineMultipeptide Cancer Vaccine	2016	211
Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study Susanna Mandruzzato, Sven Brandau, Cedrik M. Britten, Cancer Immunology Immunotherapy	2016	196
Activated human T lymphocytes express MHC class I heavy chains not associated with beta 2-microglobulin. E Schnabl, Hannes Stockinger, Otto Majdic, The Journal of Experimental Medicine HistocompatibilityMhc ClassHla ImmunogeneticsImmunologyImmunodominance	1990	135
Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells Despina Rudolf, Tobias Silberzahn, Steffen Walter, Cancer Immunology Immunotherapy Cell TherapyAdaptive Immune SystemMedicineImmunologySynthetic Artificial Antigen	2007	60
A Cryptic Vascular Endothelial Growth Factor T-Cell Epitope: Identification and Characterization by Mass Spectrometry and T-Cell Assays Andreas O. Weinzierl, Dominik Maurer, Florian Altenberend, Cancer Research	2008	49
High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A*02:01 molecules Andreas Moritz, Raghavendra Anjanappa, Claudia Wagner, Science Immunology	2019	45
Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining Lindsey Chudley, Katy J. McCann, Adam Coleman, Cancer Immunology Immunotherapy	2014	37
Laser Beam Melting of NdFeB for the production of rare-earth magnets Tobias Kolb, Florian Huber, Basri Akbulut, EngineeringMechanical EngineeringLaser ApplicationsLaser MaterialLaser Beam Melting	2016	36

Page 1